Related Experiment Video
Updated: May 28, 2026

Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro
Published on: April 21, 2023
Antimicrobial activity of gallium maltolate against Staphylococcus aureus and methicillin-resistant S. aureus and
Carolyn E Arnold1, Angela Bordin, Sara D Lawhon
1Department of Large Animal Clinical Sciences, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, TX 77843-4475, USA. Carnold@cvm.tamu.edu
Abstract:
Gallium is a trivalent semi-metallic element that has shown antimicrobial activity against several important human pathogens. This antimicrobial activity is likely related to its substitution in important iron-dependent pathways of bacteria. The genus Staphylococcus, which includes human and animal pathogens that cause significant morbidity and mortality, requires iron for growth and colonization. In this study, gallium maltolate, at various concentrations between 50 and 200μM, inhibited the in vitro growth of Staphylococcus aureus and methicillin-resistant S. aureus (MRSA) at time-points between 8 and 36h after inoculation. The inhibitory activity of gallium maltolate against clinical isolates of MRSA and methicillin-resistant Staphylococcus pseudintermedius (MRSP) from a veterinary teaching hospital was determined.
Insights
Gallium maltolate effectively inhibited the growth of Staphylococcus aureus and methicillin-resistant strains in vitro. This finding suggests gallium
Area of Science:
- Microbiology
- Antimicrobial Research
- Inorganic Chemistry
Background:
- Gallium, a semi-metallic element, exhibits antimicrobial properties by interfering with bacterial iron-dependent metabolic pathways.
- Staphylococcus species, including human and animal pathogens, rely on iron for growth and colonization.
- Methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus pseudintermedius (MRSP) are significant causes of morbidity and mortality.
Purpose of the Study:
- To evaluate the in vitro antimicrobial activity of gallium maltolate against Staphylococcus aureus and MRSA.
- To determine the efficacy of gallium maltolate against clinical isolates of MRSA and MRSP.
Main Methods:
- In vitro growth inhibition assays were performed using various concentrations of gallium maltolate (50–200μM).
- Bacterial growth was monitored over time (8–36 hours post-inoculation).
- Testing included standard strains and clinical isolates of MRSA and MRSP.
Main Results:
- Gallium maltolate demonstrated significant in vitro inhibition of Staphylococcus aureus and MRSA growth.
- The inhibitory effect was observed at concentrations ranging from 50 to 200μM.
- Activity was confirmed against clinical isolates of MRSA and MRSP.
Conclusions:
- Gallium maltolate possesses potent in vitro antimicrobial activity against clinically relevant Staphylococcus species.
- Gallium maltolate represents a potential therapeutic agent for infections caused by S. aureus, MRSA, and MRSP.
- Further research into gallium-based compounds for treating staphylococcal infections is warranted.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Antimicrobial Effectiveness
